Kodiak Sciences Quarterly Cash Flow Statement
NASDAQ: KODHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
99.87+5.61 (+5.95%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kodiak Sciences free cash flow
In the quarter ended Jun 30, 2026, Kodiak Sciences generated -$46.2 million of operating cash flow and spent $352,000 on capital expenditures. That left free cash flow of -$46.6 million.
Summary generated from market data by MetaCap's automated system. Methodology
Kodiak Sciences cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -65.64M | -58.16M | -56.74M | -61.46M | -54.31M | -57.46M | -44.10M | -43.95M | -45.12M | -43.04M | -59.52M | -50.01M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 4.11M | 4.11M | 4.54M | 4.59M | 4.59M | 4.60M | 4.63M | 4.68M | 4.70M | 4.70M | 4.73M | 5.00M |
| Stock-Based Compensation | 11.61M | 12.15M | 13.29M | 14.05M | 15.64M | 15.89M | 8.62M | 14.81M | 18.38M | 18.41M | 22.83M | 13.95M |
| Change in Working Capital | 997.00K | -741.00K | 1.63M | 5.30M | -1.47M | 2.67M | 649.00K | 1.70M | -946.00K | -11.11M | 2.50M | -206.00K |
| Operating Cash Flow | -46.24M | -40.01M | -39.38M | -32.88M | -34.67M | -29.08M | -30.07M | -21.16M | -26.49M | -39.60M | -32.24M | -32.76M |
| Capital Expenditures | -352.00K | -942.00K | -43.00K | -60.00K | -133.00K | -270.00K | -124.00K | -180.00K | -49.00K | -22.00K | -27.48M | -226.00K |
| Investing Cash Flow | -352.00K | -942.00K | -43.00K | -60.00K | -133.00K | -270.00K | -124.00K | -205.00K | -260.00K | -166.00K | -27.80M | -226.00K |
| Financing Cash Flow | 2.96M | 619.00K | 177.25M | 813.00K | 120.00K | 124.00K | 404.00K | 0 | 59.00K | 38.00K | -124.00K | -12.00K |
| Net Change in Cash | -43.63M | -40.33M | 137.82M | -32.13M | -34.69M | -29.22M | -29.79M | -21.36M | -26.69M | -39.73M | -60.16M | -33.00M |
| Free Cash Flow | -46.59M | -40.95M | -39.42M | -32.94M | -34.81M | -29.35M | -30.19M | -21.34M | -26.54M | -39.62M | -59.72M | -32.99M |
This table shows 12 quarterly periods of Kodiak Sciences's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow KOD's reporting calendar. What is a cash flow statement?